Accendra Health Inc(ACH) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 7:53 PM ET (Korea 9/12 08:53)
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -3.92 | Insider Own | 9.42% | Shs Outstand | 76.9M | Perf Week | -11.48% |
| Market Cap | 0.08B | Forward P/E | 5.92 | EPS next Y | 843.9% | Insider Trans | - | Shs Float | 69.7M | Perf Month | -10.74% |
| Enterprise Value | 1.90B | PEG | - | EPS next Q | 0.01 | Inst Own | 81.46% | Short Float | 12.68% | Perf Quarter | -66.36% |
| Income | -0.30B | P/S | 0.03 | EPS this Y | -98.09% | Inst Trans | -0.2% | Short Ratio | 7.58 | Perf Half Y | -54.24% |
| Sales | 2.65B | P/B | - | EPS next 5Y | - | ROA | -3.53% | Short Interest | 8.83M | Perf YTD | -61.43% |
| Book/sh | -7.16 | P/C | 10.86 | EPS past 3/5Y | - | ROE | -198.35% | 52W High | -81.02% ($5.69) | Perf Year | -80.26% |
| Cash/sh | 0.1 | P/FCF | - | Sales past 3/5Y | -34.78% -20.1% | ROIC | -24.56% | 52W Low | 15.67% ($0.93) | Perf 3Y | -93.45% |
| Dividend Est. | - | EV/EBITDA | 6.49 | EPS Y/Y TTM | 74.88% | Gross Margin | 39.89% | Volatility(W/M) | 9.33% 10.36% | Perf 5Y | -96.96% |
| Dividend TTM | - | EV/Sales | 0.72 | Sales Y/Y TTM | -69.68% | Oper. Margin | 1.35% | ATR (14) | 0.15 | Perf 10Y | -96.76% |
| Dividend Ex-Date | 2022/6/30 | Quick Ratio | 0.3 | EPS Q/Q | 89.72% | Profit Margin | -11.41% | RSI (14) | 29.01 | Recom | 3.4 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.41 | Sales Q/Q | -10.07% | SMA20 | -7.02% ($1.16) | Beta | 1.51 | Target Price | $1.56 |
| Payout | - | Debt/Eq | - | Earnings | 2026/8/10 | SMA50 | -52.56% ($2.28) | Rel Volume | 0.77 | Prev Close | $1.08 |
| Employees | 6500 | LT Debt/Eq | - | EPS/Sales Surpr. | -126.73% -2.46% | SMA200 | -58.68% ($2.61) | Avg Volume(3M) | 1.17M | Price | $1.08 |
| IPO | 1982/11/1 | Option/Short | Yes/Yes | Trades | 2216 | Volume | 902,564 | Change | - |
Company
ACH is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
Accendira Health (ACH) is a US-based home healthcare company serving patients across the country. The company supplies a portfolio of essential medical products for home use, including diabetes care, sleep health, wound care, respiratory, and urology products. With its Apria and Byram brands, Accendira Health is focused on the home medical market.
Over the past 1 year, on the lower side
81% below its 1-year high.
ACH has weak earning power
1.35% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by -98.1% this year.
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Would have changed by -93.5% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership is about average
Institutions hold 81.5%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
APPC 0.01%
FFLS 0.01%
BTR 0.01%
XCCC 0.00%
MYHD 0.00%Special products that amplify (leveraged) or invert this single stock. They decay quickly and are not for long-term holding.
QTUM 5.5B
FAI 186M
XAIX 173M
QTUP 16M
ARCX 7MIt ranks #4 in the industry
Based on market cap of $83M.
ACH $83M PER -
MCK $103B PER 23.6
COR $61B PER 23.9
CAH $55B PER 32.4
FAQ
What kind of company is ACH?
ACH belongs to the Healthcare sector and operates in the Medical Distribution industry.
What is the market cap of ACH?
The market cap of ACH is approximately $83M, ranking 4,672 within its sector.
What is the 52-week high and low for ACH?
ACH has recorded a 52-week high of $5.69 and a low of $0.93.
